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ABSTRACT
Plasmacytoid dendritic cells (pDCs) are potent producers of type I IFN (IFN-I) during viral infection and respond to IFN-I in a positive
feedback loop that promotes their function. IFN-I shapes dendritic cell responses during helminth infection, impacting their ability to
support Th2 responses. However, the role of pDCs in type 2 inflammation is unclear. Previous studies have shown that pDCs are
dispensable for hepatic or splenic Th2 responses during the early stages of murine infection with the trematode Schistosoma mansoni
at the onset of parasite egg laying. However, during S. mansoni infection, an ongoing Th2 response against mature parasite eggs is
required to protect the liver and intestine from acute damage and how pDCs participate in immune responses to eggs and adult
worms in various tissues beyond acute infection remains unclear. We now show that pDCs are required for optimal Th2 cytokine
production in response to S. mansoni eggs in the intestinal-draining mesenteric lymph nodes throughout infection and for egg-
specific IFN-g at later time points of infection. Further, pDC depletion at chronic stages of infection led to increased hepatic and
splenic pathology as well as abrogated Th2 cell cytokine production and activation in the liver. In vitro, mesenteric lymph node pDCs
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supported Th2 cell responses from infection-experienced CD4+ T cells, a process dependent on pDC IFN-I responsiveness, yet
independent of Ag. Together, these data highlight a previously unappreciated role for pDCs and IFN-I in maintaining and reinforcing
type 2 immunity in the lymph nodes and inflamed tissue during helminth infection. ImmunoHorizons, 2021, 5: 721–732.
INTRODUCTION
Plasmacytoid dendritic cells (pDCs) are known for potent pro-
duction of type I IFN (IFN-I), which is especially important for
innate activation during viral infection (1, 2). Recent studies
demonstrated that pDCs can develop from a lymphoid, as well
as myeloid precursor population, and thus, the majority of
pDCs belong to a separate lineage from conventional dendritic
cell (cDC) subsets (3, 4). Although pDCs can express MHC
class II (MHC II) and costimulatory molecules (5, 6), they do
not stably express MHC II and exogenous Ag on their surface,
they lack essential Ag-processing machinery (7, 8), and they
express a very restricted suite of pattern-recognition receptors
(9), making their relevance as an APC population uncertain.
Thus, more broadly, the role of pDCs and their function beyond
provision of IFN-I in settings outside of viral infection, such as
during type 2 inflammation, remains unclear.
pDCs can be found in the T cell zones of peripheral lymph
nodes (LNs) in the steady state, and their migration into this
site is enhanced under inflammatory conditions, such as during
bacterial or viral infection (10, 11). Additionally, pDCs home to
the intestines in specific settings (10, 12) and exert influence on
intestinal immune status, for example, by orchestrating toler-
ance against orally delivered Ags in the mesenteric LNs
(MLNs) (12, 13). The gastrointestinal tract, along with the liver,
is one of the primary sites affected by infection with the medi-
cally important helminth Schistosoma mansoni (14), in which
egg transit through tissues causes significant damage and leads
to the development of a Th2 response (14, 15). These observa-
tions suggest a potential role for pDCs in modulating immune
responses in the tissue during helminth infection. As we have
recently shown that cDC populations induce egg-specific Th2
responses in the MLNs (16), pDCs are likely not important
APCs in this context, and the role of pDCs in supporting Th2
response to eggs and their Ags remains unknown.
pDCs are the primary producers of IFN-I in antiviral
responses (7), and pDC activation and function, including IFN-
I production, is dependent on an IFN-I autocrine feedback
loop via pDC expression of IFNAR, the IFN-I receptor (1719).
pDC-derived IFN-I can also drive optimal cDC function during
viral infection (20). IFN-I activation in mice also occurs in
response to several helminths and their Ags, including S. man-
soni, Heligmosomoides polygyrus, and Nippostrongylus brasilien-
sis (2124). Further, cDCs require IFN-I signaling via the
IFNAR to initiate type 2 responses against type 2 Ag (21, 22).
In response to S. mansoni egg Ag, cDCs, not pDCs, are the pri-
mary source of IFN-I (21). However, whether IFN-I influences
pDC function during type 2 inflammation or pDCs are required
for Th2 responses during active S. mansoni infection at the egg
laying or chronic stages remains unclear.
In murine models of allergic airway inflammation, rather
than acting as APCs in priming type 2 immunity, pDCs can
negatively regulate Th2 activation (25, 26). TLR7/8 activation
can initiate pDC production of IFN-I that inhibits the function
of lung group 2 innate lymphoid cells (ILC2s), reducing airway
hypersensitivity (27). In contrast, a recent report suggested that
pDC accumulation in the lung during viral infection facilitates
type 2 allergic airway exacerbations in an OVA-driven model,
with Ab-mediated depletion of pDCs reducing type 2 cytokines
in the draining LNs (dLNs) (28). In humans, along with cDCs,
pDC numbers in the blood are increased during infection with
the soil-transmitted nematode Strongyloides stercoralis, com-
pared with numbers in endemic healthy and anthelmintic-
treated individuals (29). We previously demonstrated that
unlike reports from allergic airway models, negative regulation
of type 2 inflammation is not a hallmark pDC function in the
early stages of S. mansoni infection (6). Further, pDCs are not
essential for promoting Th2 responses in the liver or spleen
during the early stages of infection when egg laying has just
recently commenced (6). Despite this, hepatic pDCs isolated ex
vivo are able to support OVA-specific TCR transgenic CD41 T
cell production of IL-13 in vitro. These data implicated a role
for pDCs in promoting development or maintenance of the
adaptive immune response against S. mansoni.
In this study, we have addressed the impact of pDC deple-
tion on T cell cytokine production in the intestine-draining
MLNs during active S. mansoni infection. We found that pDCs
supported optimal Th2 cytokine production at this site at the
onset of parasite egg laying, as well as during the shift to
chronic infection. However, pDCs were not fundamentally
required for Th2 priming in the skin-draining popliteal LNs
(PLNs) following s.c. injection of S. mansoni eggs, an in vivo
model of acute egg challenge. Nevertheless, a role for pDCs
during active S. mansoni infection was also evident in other tis-
sue sites at later stages of infection, with hepatic and splenic
pathology exacerbated by increased parasite egg burdens, and
the hepatic Th2 response severely abrogated, by pDC depletion
later in infection. Together, these data suggest that pDCs have
a dynamic role to play at both priming and effector sites
affected by egg transit during S. mansoni infection. Importantly,
MLN pDCs capably supported type 2 cytokine production by
infection-derived MLN CD41 T cells, dependent on pDC
expression of IFNAR1, a subunit of the IFNAR. The role of
pDCs was not limited to enhancing Th2 responses, as optimal
IFN-g production in response to egg challenge and patent S.
mansoni infection also depended on the presence of pDCs in
the dLNs. Thus, to our knowledge, we have identified a previ-
ously unappreciated role for pDCs in supporting established
CD41 T cell effector responses during chronic helminth
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infection and demonstrate a novel requirement for pDC IFN-I
responsiveness to enable optimal Th2 responses.
MATERIALS AND METHODS
Mice, infections, and immunizations
BDCA-2diphtheria toxin receptor (DTR), Ifnar1/, and KN2
female mice, on the C57BL/6 background, were bred and main-
tained at the University of Manchester under specific pathogen-
free conditions (3032). Control C57BL/6 (wild-type [WT]) mice
were either bred and maintained in-house or obtained commer-
cially from Harlan. Experimental mice were infected percutane-
ously with 4080 cercariae. S. mansoni eggs were isolated
from C57BL/6 mouse livers and stored at 80C before being
used to immunize mice s.c. in each rear footpad, with 2500 eggs
in 50 ml PBS. For pDC depletion, mice were injected i.p. every
48 h from day 32 (d32) to d42 or d42 to d56 with 4 ng/g diph-
theria toxin (Sigma-Aldrich) in PBS. Endotoxin-free soluble egg
Ag (SEA) from S. mansoni was prepared in-house as previously
described (33). All experiments were conducted under a license
granted by the Home Office of the United Kingdom, in accor-
dance with local guidelines.
Provision of parasite material
The life cycle of the Naval Medical Research Institute (Puerto
Rican) strain of S. mansoni was maintained by routine infec-
tions (180 cercariae) of female HsdOla:TO (Tuck Ordinary,
Envigo) mice obtained from Harlan and Biomphalaria glabrata
(NMRI albino and pigmented hybrid) snails (12 miracidia per
snail) at Aberystwyth University. All procedures performed on
mice adhered to the United Kingdom Home Office Animals
(Scientific Procedures) Act of 1986 (project license PPL 40/
3700 and P3B8C46FD) as well as the European Union Animals
Directive 2010/63/EU and were approved by Aberystwyth Uni-
versitys Animal Welfare and Ethical Review Body.
Flow cytometry
Following cell isolation, cell populations were assessed by flow
cytometry. Cells were first stained with LIVE/DEAD Fixable
Aqua or UV (Thermo Fisher Scientific) and, following Fc
receptor block, were stained with combinations of the following
mAb: CD4, CD11b, CD11c, CD40, CD44, CD45R, CD64, CD80,
CD86, CD205, CD317, lineage (CD3, CD19, CD49b, Ly-6G, and
NK1.1), F4/80, Foxp3, human CD2 (huCD2), Ly-6C, MHC II,
TCRb, and XCR1. All Abs for flow cytometry were purchased
from BD Biosciences, Thermo Fisher Scientific, or BioLegend.
Samples were acquired on an FACS LSR or LSRFortessa flow
cytometer using BD FACS Diva Software and analyzed with
FlowJo 9 software (Tree Star) to ascertain proportional expres-
sion of markers. When gating on dendritic cell (DC) popula-
tions, cells were gated on live, singlet, lineage cells, and
monocytes (Ly-6ChiCD11bhi) and macrophages (F4/801CD641)
were first excluded from analysis. pDCs were gated as Ly-
6CmidCD11bCD11cmidCD3171CD45R1, cDC1s as CD11chiMHC
IIhiCD11bloCD205hi/XCR1hi, and cDC2s as CD11chiMHC IIhi
CD11bhiXCR1lo/CD205lo. T regulatory cells (Tregs) were gated
as TCRb1NK1.1CD41Foxp31 and T effector cells (Teff) as
TCRb1NK1.1CD41Foxp3CD44hiCD62Llo.
S. mansoni egg counts
Livers and intestines from infected mice were digested in 4%
potassium hydroxide (15 ml/g liver tissue; 7.5 ml/g intestine tis-
sue) at 37C overnight. One-hundred-microliter aliquots of the
digests were evaluated on gridded petri dishes, and the eggs
were counted at 10 magnification. Each digest was examined
in triplicate, and the mean results were used to extrapolate the
total number of eggs per gram of tissue.
Restimulation assays
Livers were perfused, diced, and digested at 37C for 45 min
using 0.4 U/ml Liberase (Roche Diagnostics) and 80 U/ml
DNase I Type IV (Sigma-Aldrich). The digested liver was then
passed through a 100-mm cell strainer with the aid of a syringe
plunger. Leukocytes were separated from other liver cells by
resuspension in 33% isotonic Percoll (GE Healthcare) and cen-
trifugation at 700  g. Pelleted cells were resuspended and
passed through a 40-mm cell strainer to obtain a single-cell sus-
pension and remove S. mansoni eggs. RBCs were ammonium
chloridepotassium lysed, and cells were counted and resus-
pended for use. Single-cell suspensions of PLN, MLN, or liver
leukocytes (1  106 cells/ml) were cultured in X-VIVO 15
Medium (Lonza) containing 2 mM L-glutamine and 50 mm 2-
ME (Thermo Fisher Scientific) in 96-well plates at 37C 5%
CO2 with, or without, 15 mg/ml SEA. After 72 h, supernatants
were harvested and analyzed for IL-4, IL-5, IL-10, IL-13, and
IFN-g using paired mAb and recombinant cytokine standards
(BioLegend and PeproTech). Medium alone values were sub-
tracted from Ag-restimulated cytokine levels for each sample.
Coculture assays
pDCs and T cells were FACS sorted from the MLNs of S. man-
soniinfected animals. This assay was set up as previously
described (21, 34). Fifty thousand CD41 T cells were cultured
in 96-well plates for 3 d with 2500 pDCs with, or without, 1
mg/ml anti-CD3 (produced in-house). On d3, either superna-
tants were taken for cytokine analysis by ELISA or cells were
analyzed for huCD2 expression (IL-4 production) by flow
cytometry.
Statistical analysis
Statistical analysis was carried out using JMP software (SAS),
analyzed using linear mixed effects models with a fixed effect
of experimental group and a random effect of experiment day,
to account for any significant differences between experiments.
Model assumptions of normality and homogeneous variance
were assessed by a visual analysis of the raw data and the
model residuals. Right-skewed data were log or square root
transformed. Experimental groups were considered statistically
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significant if the fixed effect F test p value was #0.05. Post hoc
pairwise comparisons between experimental groups were made
using Tukey honest significance difference multiple-comparison
test. Statistical outliers were identified using the extreme stu-
dentized deviate method and omitted prior to the mixed effect
model analysis. Graphs of results were shown as mean 6 SEM
of untransformed data using Prism version 6 (GraphPad).
RESULTS
S. mansoni infection alters the proportion, number, and
activation status of MLN DC subsets
During S. mansoni infection, a high proportion of eggs released
by adult female worms are forced into the liver by blood flow
in the portal vein. However, to perpetuate the helminth life-
cycle, some eggs must rupture through the intestinal wall to
exit the host (14, 15). Egg transit causes significant pathology in
the intestine, as well as the liver, over the course of infection.
We have previously shown that egg injection into the intestinal
serosa elicits Ag-bearing cDCs to migrate to the MLNs, where
they promote Th2 polarization (16). However, little is known
about which DC subsets are evident in the MLNs over the
course of active S. mansoni infection.
To address this question, we harvested MLN cells at differ-
ent time points throughout S. mansoni infection (Fig. 1A).
Assessment began at d28 of infection, around the time that
adult female worms start to deposit eggs that transit through
the tissues (14). The window between d28 and d42 of infection
also induces acute Th2 priming, predominantly in response
to egg Ag. By later, chronic, time points from around d56 of
infection, mice develop extensive Th2-driven immunopathology
and display a more regulatory immunophenotype (14). Compar-
ing d28, d42, and d56 postinfection, we found that the propor-
tion of pDCs (CD3171Ly-6C1CD11c1; Fig. 1B) within the
MLNs was significantly increased in mice at both d28 and d56
of infection compared with naive mice and that the total num-
bers of pDCs were increased compared with naive at d4256 of
infection (Fig. 1C). Frequencies of cDC subsets, defined as
cDC1s or cDC2s according to their differential expression of
surface markers CD11b and CD205/XCR1 (Fig. 1B) (35), did not
change throughout infection as a proportion of all live cells.
Similarly, the total number of cDC1s was significantly increased
at d4256 of infection compared with naive animals, whereas
cDC2s transiently increased in number at d42 of S. mansoni
infection (Fig. 1C). At every time point, pDCs remained a
smaller percentage of total MLN cells and a smaller number of
cells than cDC1s or cDC2s, as previously shown in the liver
during S. mansoni infection (6).
Although cDC expression of MHC II and costimulatory mol-
ecules is essential for CD41 T cell priming (36), minimal upregu-
lation of these surface markers has been reported against
helminths, including in splenic cDCs and pDCs during S. man-
soni infection (37). In agreement with this, we observed no sig-


















































































































































































































































FIGURE 1. The kinetics and activation of DC populations over the course of S. mansoni infection.
(A) C57BL/6 WT mice were infected with 40–80 S. mansoni cercariae on d0, and MLNs harvested from naive (N) mice, and at d28, d42, and d56
of infection. (B) Representative plots of MLN DC gating. (C) Percentage of total live cells and total numbers of pDCs, cDC1s, and cDC2s in N or S.
mansoni–infected (Sm) MLNs. (D) Fold change in geometric mean fluorescence intensity (gMFI) of MHC II, CD40, CD80, and CD86 on the surface
of DC subsets over the course of infection, normalized to expression levels on cells from control mice. Results are mean 6 SEM. Data from two
experiments pooled (n 5 4–13 mice per group) and analyzed using a linear fixed effect model with pairwise comparison. *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001.
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intensity) on all DC subsets in the MLNs of infected compared
with naive mice (Fig. 1D), with MHC II levels in fact decreasing
in mice between d42 and d56 of infection. MLN pDCs signifi-
cantly upregulated CD40 expression on their surface at d28 of
infection compared with cells from naive mice, whereas cDC
subsets only upregulated CD40 compared with controls around
the development of chronic infection at d56. Thus, the MLN
pDC population was responsive to S. mansoni infection during
the early stages of the immune response, before egg production,
highlighting the potential for a previously unappreciated role for
pDCs at this site following schistosome infection.
pDCs are required for optimal Th cytokine responses in
the gut-draining LN during S. mansoni infection
pDC depletion early in S. mansoni infection (d3242 postinfec-
tion) has no significant effect on Th2 development in the liver
or spleen (6), but the impact of pDCs on the Th2 response at
other sites affected by egg transit or at other time points after
S. mansoni infection has remained unclear. To assess the influ-
ence of pDCs on Th cell development in the gut-draining
MLNs during S. mansoni infection, we used BDCA-2DTR,
pDC-depletable mice that express the human DTR gene under
control of the promoter for BDCA-2, a marker of human pDCs,
for effective and specific pDC depletion (30). We first depleted
pDCs between d32 and d42 of S. mansoni infection (Fig. 2A), a
timeframe that correlates with the onset of egg deposition and
the commencement of Th2 priming and our previous assess-
ment of the impact of pDCs and CD11c1 cell depletion on
hepatic and splenic Th2 responses during infection (6, 38). The
proportion of pDCs from total live cells was variable in the
MLNs of WT and diphtheria toxin (DTx) treated animals (Fig.
2B); thus, calculated pDC depletion at this site was roughly
50% in naive mice and 3540% depletion in S. mansoni-
infected animals (Fig. 2C). Despite incomplete depletion of
pDCs in the MLNs, levels of parasite-specific IL-4 and IL-13
produced by MLN cells, as measured by ELISA of cell-free
supernatants, were significantly impaired in infected animals
following pDC depletion on d3242 postinfection (Fig. 2D),
suggesting a potential site-specific role for pDCs in promotion
of the Th2 cell response. To investigate the role of pDCs later
in infection, when the Th2 response is in a more chronic phase
(14), we next depleted pDC populations from d42 to d56 of
infection (Fig. 2E), 24 wk after initial onset of egg deposition.
This led to more robust pDC depletion in the MLNs at this
time point (Fig. 2F, 2G) and defective S. mansoni egg Ag-spe-
cific recall responses in the MLNs, including a significant
reduction in IL-5, IL-13, and IFN-g production (Fig. 2H).
Although Ag-specific IL-4 from MLN cells was reduced follow-
ing pDC depletion earlier in infection, at this time point, egg-
specific IL-4 was not significantly impacted.
Parasitemia was unaltered after pDC depletion by DTx
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FIGURE 2. pDCs are required for optimal T cell cytokine production in the gut-draining LN throughout S. mansoni infection.
WT or BDCA-2–DTR (DTR) mice were infected with 40–80 S. mansoni (Sm) cercariae on d0 (naive [N]). For assessment of pDCs in acute infec-
tion from d32 until d42 (A), or for assessment at the onset of chronic infection, from d42 until d56 (E), mice were treated i.p. with DTx before MLN
harvest. (B and F) Proportion and total numbers of pDCs from MLN cells on d42 (B) or d56 (F) of infection. (C and G) pDC depletion in DTR mice
calculated compared with pDC percentages in WT mice on d42 (C) or d56 (G) of infection. (D and H) After SEA restimulation, or culture with
medium alone, MLN cell-free supernatants were analyzed by ELISA for a schistosome egg-specific recall cytokine response. Medium alone values
were subtracted from Ag-restimulated samples. Results are mean 6 SEM. Data from three experiments pooled (n 5 4–12 mice per group) analyzed
using a linear fixed effect model with pairwise comparison. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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2DTR mice displaying similar egg burdens in the liver and gut
(Fig. 3A) and similar or diminished immunopathology at d42 of
S. mansoni infection (Fig. 3B). In contrast, there was a signifi-
cant increase in liver egg counts and a trend for increased
intestinal egg deposition following depletion at the later time
point (Fig. 3C), accompanied by significantly heightened
splenomegaly and hepatomegaly (Fig. 3D). Thus, defective Th2
cytokine levels in the absence of pDCs could impact the ability
of the host to tolerate infection as it reaches chronicity.
We addressed the possibility that other DC populations
could be altered in response to pDC depletion and found that
DTx treatment of WT or BDCA-2DTR animals had no impact
on monocyte, macrophage (6), or cDC subset frequencies in
d42 S. mansoniinfected mice (Supplemental Fig. 1A), although
there was a minor decrease in cDC1s in the MLNs of some
naive DTx-treated BDCA-2DTR mice. At d56 of infection,
there was a significant increase in cDC2s in the MLNs and sig-
nificant decrease in liver cDC1s in both WT and BDCA-2DTR
mice compared with naive controls (Supplemental Fig. 1B).
Thus, non-pDC DC subset alteration does not likely influence
the deficit in Th2 cytokine responses in the MLN following
pDC depletion at d3242 or d4256 postinfection. Together,
these data demonstrated that pDCs were required for optimal
CD41 T cell Th2 development in the gut-draining MLNs over
the course of active S. mansoni infection, from early after com-
mencement of egg laying. Further, pDCs were required for
IFN-g production at later stages of infection.
pDCs are not required for Th2 priming against S. mansoni eggs
CD11c1 myeloid cells are required for optimal Th2 induction
following murine S. mansoni infection or egg injection (38),
with pDCs specifically promoting CD41 T cell cytokine
responses to eggs Ags in the MLNs during infection (Fig. 2). To
directly address whether pDCs are required for Th2 priming
against schistosome eggs, we injected PBS- or DTx-treated WT
or BDCA-2DTR mice s.c. with PBS or S. mansoni eggs
(Supplemental Fig. 2A), a system widely used to investigate
acute type 2 response induction to eggs in the dLNs without
the additional complexities involved in ongoing infection (34,
38). DTx treatment had no significant impact on Th2 develop-
ment or egg-specific IFN-g production following s.c. S. mansoni
egg injection (Supplemental Fig. 2B), even though PLN pDCs
were efficiently depleted in egg-injected mice (Supplemental
Fig. 2CE), with no impact on cDC populations (Supplemental
Fig. 2F, 2G). Thus, pDCs were not required for Th cell polari-
zation in a model of acute egg challenge but rather were a key
contributing cell type for optimal Th2 and Th1 cytokine
responses during patent S. mansoni infection (Fig. 2).
pDCs sustain MLN CD41 T cell responses during chronic
S. mansoni infection
To better understand the function of pDCs in Th responses
during S. mansoni infection, we began by analyzing the influ-
ence of pDC depletion on CD41 T cell subpopulations in this
context. There was no significant impact of pDC depletion on
proportions or total numbers of CD441CD62LloCD41 Teff or
Foxp31 Treg in the MLNs of infected mice at d42 after pDC
depletion (Fig. 4A, 4B). At d56 of infection, there was a compa-
rable increase in the proportion of Teff, but not Tregs, in both
WT and BDCA-2DTR mice compared with naive controls
(Fig. 4C). However, when total numbers of CD41 T cell popu-
lations were assessed at this time point, there was a significant
Depletion: d42-56Depletion: d32-42






























































































































































































FIGURE 3. pDCs are required to restrain parasite
egg laying and host pathology during chronic S.
mansoni infection.
Naive (N) and S. mansoni–infected WT or DTR mice
were treated with DTx, as in Fig. 1. On d42 (A) or
d56 (C) of S. mansoni infection, livers and small
intestines were isolated from infected animals, and
parasite egg counts were performed. (B and D)
Splenomegaly and hepatomegaly determined by
spleen and liver weights as a percentage of total
body weight on d42 (B) or d56 (D) of S. mansoni
infection. Results are mean 6 SEM. Data from two
(C and D) or four (A and B) experiments pooled (n 5
7–20 mice per group) analyzed using a linear fixed
effect model with pairwise comparison. *p < 0.05,
**p < 0.01, ****p < 0.0001.
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impairment in expansion of both Teff and Tregs in the MLNs
of DTx-treated S. mansoniinfected BDCA-2DTR mice com-
pared with WT controls (Fig. 4D). These data demonstrate that
pDCs have a key role to play in the development or mainte-
nance of both effector and regulatory CD41 T cell populations
as S. mansoni infection progresses from d42 to d56.
pDCs can support Th2 cytokine production by MLN T cells
isolated from S. mansoni infection
Having demonstrated that pDCs were essential both for opti-
mal Th2 cytokine and IFN-g output by MLN cells (Fig. 2), we
next addressed whether MLN pDCs from active S. mansoni
infection could directly enhance cytokine production by infec-
tion-derived MLN CD41 T cells. To do so, pDCs sorted from
the MLNs of naive mice or mice at d42 of S. mansoni infection
were cultured with MLN CD41 T cells also isolated from d42
infected mice (Fig. 4E). MLN pDCs from either naive or
infected mice significantly enhanced levels of Th2 cytokine pro-
duction by CD41 T cells isolated from infected animals, com-
pared with that observed from T cells cultured alone (Fig. 4F).
These data demonstrate that pDCs, although incapable of prim-
ing Th2 polarization of naive T cells (6), could competently
support Th2 cytokine production from infection-derived, Ag-
experienced, CD41 T cells. Of note, in this context, pDCs failed
to significantly enhance CD41 T cell IFN-g production.
IFN-I signaling via IFNAR can promote optimal DC activa-
tion and function during inflammation (1720), including during
type 2 immune activation driven by helminth Ag, in which cDC
induction of Th2 responses is dependent on their ability to
respond to IFN-I (21, 22). Further, IFN-I is produced in vivo in
response to helminths, including following immunization with S.
mansoni egg Ag and during active S. mansoni infection (21, 24).
To investigate whether pDC promotion of type 2 cytokine pro-
duction from CD41 T cells was also facilitated by IFN-I respon-
siveness, we isolated pDCs from the MLNs of WT or Ifnar1/ S.
mansoniinfected mice and cocultured them with CD41 T cells
isolated from infected WT KN2 cytokine reporter mice, which
express huCD2 on their surface when IL-4 is produced (21, 32).
Optimal pDC-mediated support of type 2 cytokine produc-
tion from infection-derived CD41 T cells was dependent on
the ability of pDCs to respond to IFN-I, as the percentage of
huCD21 CD41 T cells was significantly reduced when pDCs
were Ifnar1 deficient, in comparison with WT cells (Fig. 4G).
Thus, the ability of pDCs to facilitate type 2 cytokine produc-

































































































































































































































































































































































































FIGURE 4. pDCs from S. mansoni–infected mice support optimal CD4+ T cell responses in vivo and Th2 polarization in vitro.
MLNs were harvested from naive (N) and S. mansoni–infected WT and DTR mice on d42 or d56 of infection, after pDC depletion from d32 to d42
or d42 to d56, respectively, and analyzed for CD41 T cell populations. (A and C) Percentage of CD41 T cells on d42 (A) or d56 (C) of S. mansoni
infection that are CD441 Teff and Foxp31 Tregs in the MLN following DTx treatment. (B and D) Total numbers of T cell populations in the MLN at
d42 (B) or d56 (D) of infection following pDC depletion. (E) Schematic to show coculture regimen. T cells from d42 S. mansoni–infected mice
were cultured for 3d with, or without, MLN pDCs from N or d42 S. mansoni–infected mice, in the presence, or absence, of anti-CD3 (aCD3). (F)
On d3 of culture, supernatants were collected from cultures and assessed for cytokine production by ELISA. Media alone values were subtracted
from anti-CD3-stimulated samples. (G) KN2 MLN T cells from S. mansoni mice were cultured in the presence or absence of WT or Ifnar1/ MLN
S. mansoni pDCs with aCD3. On d3, CD41 T cells were stained for huCD2 to identify the proportion of huCD21 (IL-41) T cells. Results are mean 6
SEM. Data from two to three experiments pooled [n 5 6–7 mice per group (A–D), n 5 8–14 wells per group (F and G)] analyzed using a linear fixed
effect model with pairwise comparison. *p < 0.05, **p < 0.05, ***p < 0.001, ****p < 0.0001.
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pDCs support hepatic Th2 cytokine responses as S.
mansoni infection progresses
We hypothesized that the impaired T cell cytokine response
evident in the MLNs of pDC-depleted mice during S. mansoni
infection might have a subsequent impact on the immune func-
tion in the effector sites, such as the liver, at later stages of
infection. This hypothesis was supported by increased egg bur-
den and pathology after depletion later in infection (Fig. 3C,
3D). DTx treatment between d42 and d56 of infection (Fig. 5A)
led to effective depletion of hepatic pDCs in BDCA-2DTR
mice (Fig. 5B, 5C) but did not significantly reduce hepatic
cDC1s or cDC2s during infection (Supplemental Fig. 1B) (39).
When we depleted pDCs at this stage of infection (from d42),
egg Ag-induced IL-4 levels in the supernatants of cultured liver
cells were significantly reduced at d56, with a trend for
decreased IL-13 levels compared with WT controls (Fig. 5D).
IL-5 and IL-10 were not significantly affected at this site or
time point, and pDCs were not required for maintaining
Ag-specific IFN-g in the liver (Fig. 5D), in contrast to the MLN
phenotype at this time point (Fig. 2). The decrease in parasi-
te-specific IL-4 and IL-13 from liver cells following pDC deple-
tion was consistent with increased splenomegaly and
hepatomegaly (Fig. 3C, 3D), the defects in MLN Th2 cytokines
(Fig. 2H) and CD41 T cell responses (Fig. 4C, 4D) evident at
this time point. Despite a minor increase in the percentage of
Tregs in pDC-depleted naive mice compared with controls, the
proportion of hepatic Teff and Tregs at d56 of S. mansoni infec-
tion was unaffected by pDC depletion (Fig. 5E). However, the
total numbers of Tregs and Teff were significantly diminished
in infected pDC-depleted mice compared with WT animals
during this phase of infection (Fig. 5F).
These data demonstrate that in addition to playing a key
role in supporting Teff responses in the MLN early during S.
mansoni infection, pDCs enhance type 2 cytokine production
and CD41 T cell responses at the liver effector site at later
stages of infection, including effective Th2 function and Treg
generation. They highlight for the first time, to our knowledge,
a key role for pDCs in supporting optimal effector CD41 T cell
responses to parasite egg Ag during S. mansoni infection in
both priming and effector sites in the MLNs and liver, respec-
tively. In the absence of pDCs, abrogated CD41 T cellmedi-
ated adaptive immunity leads to increased immunopathology,
with the potential to impact the long-term fitness and survival
of the host.
DISCUSSION
We have identified that pDCs are essential for optimal CD41 T
cell responses during chronic S. mansoni infection. An LN-spe-
cific impairment in Th2 cytokines during early infection was
associated with defective accumulation of CD441-activated
Teff and Tregs (Figs. 2, 4)the CD41 T cell subsets involved
in orchestrating, and regulating, the Th2 response in the tissue
as infection progresses (40). This then also led to a defect in
Th2 cytokine output in the effector site, the liver, at the onset
of chronic infection (Fig. 5). This defect in CD41 T celldriven
type 2 immunity in the absence of pDCs was associated with,
and likely caused, increased parasite egg deposition and exacer-
bated infection-driven pathology, resulting in worsened spleno-
megaly and hepatomegaly (Fig. 3). All together, these findings
highlight a role for pDCs in supporting optimal CD41 T cell
function during ongoing S. mansoni infection.
Our data suggest that there are site-specific differences in
the timing of a requirement for pDCs to promote optimal
immune activation against S. mansoni, comparing the liver and
MLNs. This dichotomy may relate to differences in pDC locali-
zation, as well as tissue signals and/or architecture in the
MLNs and liver during S. mansoni infection. During viral infec-
tion, pDC recruitment by CCL3/4 chemokines to T cellcDC1
clusters support T cell priming in the LN paracortex, and for-
mation of these clusters is essential for optimal T cell function
(20). Our in vitro coculture assays suggest that when pDCs and
CD41 T cells are in close proximity, pDCs from naive as well
as S. mansoniinfected mice can enhance type 2 cytokine pro-
duction (Fig. 4). Thus, as infection progresses, increased
immune cell infiltration, changes in liver architecture (Fig. 3),
and chemokine production (14) may lead to an increased role
for pDCs in promoting CD41 T cell function at this site.
Intriguingly, S. mansoni eggs produce a chemokine-binding pro-
tein that blocks chemokines, including CCL3, from binding
their receptors (41). Additionally, high CCL3 levels are associ-
ated with increased disease severity in S. mansoniinfected
mice and chronic infection in humans (42), supporting a role
for these signals in regulating immune function during S. man-
soni infection that has yet to be fully explored. Further, pDCs
infiltrate into the skin following tissue injury, where pDC IFN-
I production enhances wound healing, a process promoted by
the release of host-derived nucleic acids from damaged tissue
(43). Thus, increased tissue damage in the liver and release of
host damage signals and immune signals at later stages of infec-
tion may promote pDC function at this site as chronic S. man-
soni infection develops.
Importantly, pDC depletion was not always complete in the
MLNs, with naive and d42 infected animals showing depletion
levels below 50% in some instances, compared with the average
80% depletion we observed in other contexts (Fig. 2,
Supplemental Fig. 2). This may reflect the fact that pDCs are a
very small population in this tissue under these conditions and
so are difficult to quantify accurately. Despite this, incomplete
pDC depletion still had a significant impact on Th2 cytokine
production from MLN cells at early time points of infection
(Fig. 2D), as well as later in infection, when pDC depletion was
more consistent (Fig. 2H). pDC depletion earlier in infection
led to decreased egg-specific IL-4 and IL-13 in the MLN,
whereas depletion at d4256 caused a significant defect in
MLN IL-5, IL-13, and IFN-g, but not IL-4 (Fig. 2). This dis-
crepancy may reflect dynamic changes in the pDC and/or
CD41 T cell populations in response to chronic levels of para-
site egg deposition, evidenced by differences in absolute
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cytokine levels at different time points of infection. In this
work, we have primarily focused on the role of pDCs in activat-
ing T cell production of type 2 cytokines, but our data also
strongly support a role for pDCs in the generation of parasite-s-
pecific IFN-g. pDCs act in a supporting role to cDC1s in IFN-g
induction in other settings (20), and thus, they may co-operate
with cDC1s to promote Th1 cytokine production during S. man-
soni infection (44).
We have not assessed in this study the impact of defective
Th2 polarization in the MLNs on the effector response in the
intestinal lamina propria because of the technical difficulty of
isolating immune cells from S. mansoniinfected intestinal tis-
sue. However, we hypothesize a similar impact on Th2 cyto-
kine responses at this site given that pDCs are found
abundantly in the small intestine in naive mice (12) and can
acquire gut tropism under inflammatory conditions (10, 12, 45).
Thus, future studies should address whether pDCs also play a
role in intestinal Th2 function during S. mansoni infection.
Th2 polarization against acute egg challenge did not funda-
mentally require pDCs, at least within the first week following
exposure to S. mansoni eggs (Supplemental Fig. 2). Thus, it may
take several weeks of continuous egg deposition during infec-
tion for pDCs to become important during Th2 maintenance in
the dLNs, with this only becoming evident in effector sites at
later time points. In S. mansoni eggdriven pulmonary fibrosis,
macrophages are important for maintaining T cell responses in
the tissue, but not the dLNs (46), whereas ILC2s, basophils,
and cDCs have been implicated to play a role in promoting the
maintenance of Th2 cells and Tregs at sites of inflammation
and at mucosal barriers (4750). This highlights a potential
role for other innate cell populations in promoting optimal Th2
cytokine production in the liver at early time points. Many
pDC studies have failed to identify a role for these cells in
direct CD41 T cell priming (7). Our coculture system demon-
strated that pDCs are effective at facilitating Th2 cytokine
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FIGURE 5. pDCs are essential for effec-
tive Th2 cytokine production in the liver
in chronic S. mansoni infection.
(A) Livers were harvested from DTx-
treated naive (N) and S. mansoni–infected
WT or DTR mice on d56 of infection, as in
Fig. 1C. (B) Liver cells were purified and
analyzed by flow cytometry for the pres-
ence of pDCs, shown as a percentage of
all live leukocytes in the liver and as total
numbers. (C) pDC depletion in N and S.
mansoni DTR mice calculated by compar-
ing pDC percentages in WT and DTR
mice. (D) Supernatants from liver cells of
N and S. mansoni WT/DTR mice were cul-
tured with SEA or medium (M) alone and
analyzed by ELISA for schistosome egg-
specific recall cytokine responses. M alone
values were subtracted from Ag-restimu-
lated samples. (E and F) Percentage of liver
CD41 T cells (E) or total cell numbers
(F) that are CD44hi Teff and Foxp31 Tregs
from N/S. mansoni mice on d56 of infec-
tion. Results are mean 6 SEM. Data from
two experiments pooled (n 5 6–10 mice
per group), analyzed using a linear fixed
effect model with pairwise comparison.
*p < 0.05, **p < 0.01, ***p < 0.001, ****p
< 0.0001.
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infection, CD41 T cells without exogenous Ag (Fig. 4) (6), sug-
gesting that Ag presentation by pDCs is less important. Of note,
recent studies highlight that the majority of pDC precursors
are lymphoid, rather than myeloid (3, 4), with the suggestion
that pDCs may be redesignated as an innate lymphoid cell pop-
ulation (4). If this is indeed the case, pDCs could be compared
with ILC2s in their capacity to support Th2 function, rather
than myeloid DCs. How pDCs promote optimal CD41 T cell
function during S. mansoni infection remains to be determined.
Our coculture experiments suggest that any direct pDCT cell
interaction may not depend on Ag (Fig. 4); indeed, pDCs from
naive and S. mansoniinfected mice fail to support Ag-specific
T cell proliferation in vitro (6). Thus, pDCs may act in other
ways to potentiate Th cytokine production and CD41 T cell
subset expansion, for example, by driving T cell survival or
cytokine production.
Prior work addressing pDC function in type 2 immunity has
focused on the lung, particularly in the context of allergic air-
way models. Early studies using Ab depletion of pDCs in OVA-
driven allergic airway inflammation suggested an anti-inflam-
matory role for these cells (25, 26). In agreement with this, we
show that pDCs are required for Treg recruitment and/or
expansion in the MLNs and liver during chronic S. mansoni
infection (Figs. 4, 5). However, a coincident reduction in effec-
tor T cell populations (Figs. 4, 5) and Th2 cytokine production
(Figs. 2, 5) in the MLNs and liver is inconsistent with regula-
tion being the only role for pDCs in type 2 immunity. In agree-
ment with our results, a more recent study highlighted an
influx of pDCs into the lung following OVA-allergen challenge,
with Ab depletion of pDCs leading to reduced Th2 cytokines
and type 2mediated inflammation (27). This study highlighted
a role for OX40L and IL-25 in regulating pDC function in this
context. However, IL-25deficient mice do not display any sig-
nificant exacerbation in liver granuloma responses during
chronic S. mansoni infection (51). Thus, further work is needed
to address the importance of different type 2associated signals
for mediating pDC function in S. mansoni infection.
We have highlighted a previously unappreciated role for
IFN-I signaling in directing pDC function in type 2 inflamma-
tion (Fig. 4). Our work emphasizes that DC subsets depend on
IFN-I not only for type 2 priming by cDCs (21, 22) but also for
optimal Th2 cytokine responses supported by pDCs. We and
others have previously shown that several facets of cDC func-
tion are altered in the absence of IFN-I responsiveness, includ-
ing surface activation and migratory capacity (21, 22). In
contrast, studies investigating the role of pDCs in ILC2-medi-
ated allergic lung inflammation in response to Alternaria fungus
with IFN-Iinducing TLR ligands suggested that pDC IFN-I
inhibits ILC2-mediated type 2 immunity (28). This study is per-
haps more applicable to situations in which tissues are
responding to type 1 pathogens that drive high-level IFN-I pro-
duction alongside a type 2promoting pathogen or allergen, for
example, during virus and helminth coinfection (52). Thus, fur-
ther work is needed to address the signals that promote pDC
potentiation of Th2 cytokine output, including the importance
of parasite or host-derived Ag and the broader role of IFN-I in
type 2 immunity. In particular, it remains to be determined
whether pDCs (1720) or other cell types are the primary
source of IFN-I during helminth infection and whether pDC-
derived IFN-I plays a role in promoting CD41 T cell function.
Other potential cellular sources include cDCsshown to pro-
duce IFN-a6 in response to S. mansoni egg Ag (21) or stromal
and epithelial cells that release innate IFNs in response to dam-
age (53, 54).
In summary, we have revealed that pDCs play an integral
role in optimal Th2 cytokine responses and Treg accumulation
in both LNs and effector sites during S. mansoni infection (Figs.
2 4, 5). Impairment in immune activation following pDC deple-
tion was accompanied by a significant increase in splenic and
hepatic pathology during chronic infection, likely because of a
dramatic increase in egg deposition in the liver and gut (Fig. 3).
Further work will be needed to identify the mechanisms
employed by pDCs to influence Th2 and Treg responses, such
as whether pDCs are required for the proliferation, recruit-
ment, maintenance, or survival of T cells during S. mansoni
infection. Our work highlights a novel role for pDCs and IFN-I
during S. mansoni infection, which may have implications for
the future development of targeted immunotherapies and vac-
cines designed to combat the debilitating disease caused by this
important human pathogen.
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